Cited by 139Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismMitochondrial Function and Pathology

Evidence for a Direct Effect of the NAD+ Precursor Acipimox on Muscle Mitochondrial Function in Humans

Open access
van de Weijer, Tineke, Phielix, Esther, Bilet, Lena, Williams, Evan G., Ropelle, Eduardo R., Bierwagen, Alessandra, Livingstone, Roshan, Nowotny, Peter +12 more·2015·Diabetes

Abstract

Recent preclinical studies showed the potential of nicotinamide adenine dinucleotide (NAD+) precursors to increase oxidative phosphorylation and improve metabolic health, but human data are lacking. We hypothesize that the nicotinic acid derivative acipimox, an NAD+ precursor, would directly affect mitochondrial function independent of reductions in nonesterified fatty acid (NEFA) concentrations. In a multicenter randomized crossover trial, 21 patients with type 2 diabetes (age 57.7 ± 1.1 years, BMI 33.4 ± 0.8 kg/m2) received either placebo or acipimox 250 mg three times daily dosage for 2 weeks. Acipimox treatment increased plasma NEFA levels (759 ± 44 vs. 1,135 ± 97 μmol/L for placebo vs. acipimox, P < 0.01) owing to a previously described rebound effect. As a result, skeletal muscle lipid content increased and insulin sensitivity decreased. Despite the elevated plasma NEFA levels, ex vivo mitochondrial respiration in skeletal muscle increased. Subsequently, we showed that acipimox treatment resulted in a robust elevation in expression of nuclear-encoded mitochondrial gene sets and a mitonuclear protein imbalance, which may indicate activation of the mitochondrial unfolded protein response. Further studies in C2C12 myotubes confirmed a direct effect of acipimox on NAD+ levels, mitonuclear protein imbalance, and mitochondrial oxidative capacity. To the best of our knowledge, this study is the first to demonstrate that NAD+ boosters can also directly affect skeletal muscle mitochondrial function in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-0667

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study was approved by the institutional medical ethics committee and registered at ClinicalTrials.gov and the Dutch trial register.

    “The participants included in this study were derived from previous studies all performed at Maastricht University, approved by the institutional medical ethics committee and registered at ClinicalTrials.gov (NCT00943059 and NCT01298375) and in the Dutch trial register (https://www.trialregister.nl/trial/1888) [23–26].”

    From Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity (2021) · cites this paper as [25]

    The Research Design and Methods > Subjects section states that the Maastricht University Medical Ethics Committee approved this study. It does not report registration at ClinicalTrials.gov or the Dutch trial register, and Research Design and Methods describes participants recruited in both Maastricht and Düsseldorf, not solely at Maastricht University. No page number is available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van de Weijer, T., Phielix, E., Bilet, L., Williams, E. G., Ropelle, E. R., Bierwagen, A., Livingstone, R., Nowotny, P., Sparks, L. M., Paglialunga, S., Szendroedi, J., Havekes, B., Moullan, N., Pirinen, E., Hwang, J.-H., Schrauwen-Hinderling, V. B., Hesselink, M. K. C., Auwerx, J., Roden, M., & Schrauwen, P.
Affiliations
  • Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands
  • Maastricht University Medical Centre (NL)
  • École Polytechnique Fédérale de Lausanne (CH)
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • Düsseldorf University Hospital (DE)
  • University of Eastern Finland (FI)
  • Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany
  • School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands
Corresponding author
  • Roden, Michael
  • Schrauwen, Patrick
Venue
Diabetes
Published
2014-10-28
Volume
64
Issue
4
Pages
1193-1201
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2038391272
Cited by
139
References
43
Citations by year
2026: 2 · 2025: 15 · 2024: 10 · 2023: 15 · 2022: 16 · 2021: 13 · 2020: 15 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 10 · 2015: 9
FWCI
5.61
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • École Polytechnique Fédérale de Lausanne
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (140780)
  • Nierstichting (01C-104)
  • Diabetes Fonds (01C-104)
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (918.96.618)
  • Center for Translational Molecular Medicine (01 C-104)
  • National Institutes of Health
  • Health Science Center, University of Tennessee
  • National Institute on Aging (R01AG043930)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
acipimox, NAD+ precursors, nicotinic acid, skeletal muscle mitochondrial function, type 2 diabetes, free fatty acids, mitochondrial respiration, mitochondrial unfolded protein response, nuclear-encoded mitochondrial genes, insulin sensitivity, C2C12 myotubes, mitochondrial oxidative capacity
MeSH terms
Hypolipidemic Agents, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Mitochondria, Muscle, Pyrazines, Muscle, Skeletal, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review